Oncotelic Therapeutics, Inc.
Pharmaceutical company · Aguora Hills, California, United States · OTC: OTLC
Oncotelic Therapeutics, Inc. is a pharmaceutical company headquartered in Aguora Hills, California, United States. Its shares trade on OTC under the ticker OTLC. It has reported private securities offerings to the US SEC, most recently $275,000 sold in a notice filed in 2025.
Oncotelic Therapeutics at a glance
What does Oncotelic Therapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $275,000 sold (2025).
Frequently asked questions about Oncotelic Therapeutics
Where is Oncotelic Therapeutics headquartered?
Oncotelic Therapeutics, Inc. is headquartered in Aguora Hills, California, United States.
What does Oncotelic Therapeutics do?
Oncotelic Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Oncotelic Therapeutics a public company?
Yes. Oncotelic Therapeutics, Inc. trades on OTC under the ticker OTLC.
Similar companies
- ACELYRIN, Inc.Agoura Hills, California, United States
- OncoTelic Inc.Agoura Hills, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences